Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
Chun-Hou Liao, Hann-Chorng Kuo
Int Neurourol J. 2015;19(4):213-219.   Published online 2015 Dec 28
DOI: https://doi.org/10.5213/inj.2015.19.4.213
Citations to this article as recorded by
  Crossref logo
Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms
T. A. T. Marcelissen, M. S. Rahnama’i, A. Snijkers, B. Schurch, P. De Vries
World Journal of Urology.2017; 35(2): 307.     CrossRef
La disfunción del tracto urinario inferior en el paciente mayor
Carlos Verdejo, Santiago Méndez, Jesús Salinas
Medicina Clínica.2016; 147(10): 455.     CrossRef
Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
Hann-Chorng Kuo
Tzu Chi Medical Journal.2016; 28(3): 89.     CrossRef
New pharmacotherapy for treating overactive bladder: mirabegron and botulinum toxin
Tae Heon Kim, Kyu-Sung Lee
Journal of the Korean Medical Association.2016; 59(10): 795.     CrossRef
Urinary tract dysfunction in older patients
Carlos Verdejo, Santiago Méndez, Jesús Salinas
Medicina Clínica (English Edition).2016; 147(10): 455.     CrossRef